Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
40.7M
-
Shares change
-
+7.03M
-
Total reported value, excl. options
-
$1.21B
-
Value change
-
+$219M
-
Put/Call ratio
-
0.68
-
Number of buys
-
100
-
Number of sells
-
-70
-
Price
-
$29.60
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2017
247 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2017.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.7M shares
of 106M outstanding shares and own 38.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.29M shares), VANGUARD GROUP INC (4.1M shares), STATE STREET CORP (3.2M shares), CARLSON CAPITAL L P (1.85M shares), PERCEPTIVE ADVISORS LLC (1.77M shares), HealthCor Management, L.P. (1.55M shares), Tourbillon Capital Partners, L.P. (1.54M shares), Camber Capital Management LLC (1.35M shares), FMR LLC (1.12M shares), and ORBIMED ADVISORS LLC (1.05M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.